Markets:

Overview

News

Currencies

International

Treasuries

Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)

1.460 +0.040 (+2.82%)

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Allogene Therapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday ↗

September 29, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining around 1% on Friday. Here are some big stocks recording losses in today’s session. Corcept Therapeutics Incorporated (NASDAQ: CORT) shares...

Via Benzinga

Topics Stocks

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

September 27, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Analyst Ratings for Allogene Therapeutics ↗

September 25, 2023

Via Benzinga

Allogene Therapeutics Announces Participation in September Investor Conference

September 05, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Earnings Outlook For Allogene Therapeutics ↗

August 01, 2023

Via Benzinga

Analyst Ratings for Allogene Therapeutics ↗

June 16, 2023

Via Benzinga

Why Allogene Stock Is Trading Down Today ↗

June 14, 2023

Allogene Therapeutics, Inc. (NASDAQ: ALLO) shares are trading lower after the company announced its CFO Eric Schmidt will step down from his position.

Via Benzinga

The Next Meme Stock: 6 Tickers Leading a Meme Stock Revival

August 18, 2023

Meme stocks soared during the early days of the pandemic. Will these stocks form a major meme stock rally or a short-lived farewell tour? Learn more.

Via MarketBeat

Allogene Therapeutics Appoints Earl Douglas as General Counsel

August 14, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update

August 02, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Where Allogene Therapeutics Stands With Analysts ↗

May 26, 2023

Via Benzinga

The Latest Analyst Ratings for Allogene Therapeutics ↗

May 04, 2023

Via Benzinga

Recap: Allogene Therapeutics Q1 Earnings ↗

May 03, 2023

Via Benzinga

3 Stocks With Sky-High Short Interest Levels

July 31, 2023

BYND, BTAI, and ALLO stand out as high short-interest stocks to watch due to their potential for price fluctuations and short-squeeze opportunities.

Via MarketBeat

Allogene Therapeutics to Report Second Quarter 2023 Financial Results on August 2, 2023

July 26, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Short Squeeze Alert: The 5 Most Shorted Stocks Right Now ↗

June 22, 2023

Wondering what are the most shorted stocks this year? Here are the top five companies investors are betting against.

Via InvestorPlace

Allogene Therapeutics' Allogeneic CAR-T Therapy Proves Potential for LBCL Treatment, Analysts See Potential for First-in-Class Status ↗

June 16, 2023

Thursday, Allogene Therapeutics Inc (NASDAQ: ALLO) presented the updated data from the Phase 1 ALPHA/ALPHA2 trials of ALLO-501/501A in 33 CAR T naïve patients with relapsed/refractory (r/r) large...

Via Benzinga

Allogene Therapeutics Provides Additional ALLO-501/501A Phase 1 Data in an Oral Presentation at the International Conference on Malignant Lymphoma (ICML) Lugano

June 15, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 14, 2023

Via Benzinga

Allogene Therapeutics Announces Departure of Chief Financial Officer

June 14, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 14, 2023

Gainers WeTrade Group, Inc. (NASDAQ: WETG) shares climbed 140.3% to $20.28. WeTrade launched large-scale language processing models to increase product applications in the field of artificial...

Via Benzinga

Allogene Therapeutics Announces Oral Presentation of Phase 1 Data on ALLO-501/501A in Large B Cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) Lugano

June 09, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting

June 03, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences

May 24, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

The 3 Best Stocks to Short in May 2023 ↗

May 19, 2023

The best stocks to short are companies whose businesses aren’t faring well and have a higher-than-average short interest.

Via InvestorPlace

7 Short-Interest Stocks to Target for Explosive Gains ↗

May 18, 2023

For contrarian investors that can stand the heat, short-interest stocks to buy can offer significant rewards in a short time period.

Via InvestorPlace

As Feinstein Returns To Congress, Reports Of Her Stock Profits Upset Aaron Rodgers ↗

May 15, 2023

Sen. Dianne Feinstein of California, one of the wealthiest members of Congress, continues to draw ire for her questionable stock trading while in office. What Happened: Feinstein, 89, "has some of the...

Via Benzinga

Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress

May 11, 2023

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday ↗

May 04, 2023

U.S. stocks traded lower, with the Dow Jones falling around 400 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 04, 2023

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.